Tradestie Institutional Equity Comparison Engine

TLPH vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLPH Overall Edge

TLPH Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Talphera, Inc. Common Stock (TLPH) driven by superior Valuation, Momentum & Technical, Options & Structure while CRMD counters with relative strength in Growth & Margin. Fundamentally, TLPH trades at 1.0x Forward P/E with -1474700.0% operating margin (+0.0% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLPH
TLPH 1.0x vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin -1474700.0% vs 41.0% ยท YoY +0.0% vs -47.7%
Momentum & Technical Winner TLPH
1Y -18.0% vs -56.2% ยท 52W Pos 20% vs 3%
Options & Structure Winner TLPH
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (25th %ile IV)
TLPH NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap $53.7M
1M Return -20.29%
1Y Return -18.01%
Forward P/E 1.0x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 59.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TLPH -18.01% CRMD -56.16% Spread: +38.15 pp (TLPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TLPH TTM Op. Margin: -1474700.0% CRMD TTM Op. Margin: 41.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TLPH vs CRMD. Trailing 12-month operating profitability (TLPH -1474700.0% vs CRMD 41.0%) and valuation multiples (TLPH 1.0x vs CRMD 49.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TLPH (5) vs CRMD (5)
Institutional Metric TLPH CRMD Criterion Row Winner
Market Capitalization Scale $53.7M $384.7M Larger Scale CRMD
Trailing P/E Ratio Valuation 1.0x 2.4x Lower Multiple TLPH
Forward P/E Ratio Valuation 1.0x 49.0x Lower Multiple TLPH
Revenue Growth (YoY) Growth +0.0% -47.7% Higher Growth TLPH
Operating Margin (TTM) Profitability -1474700.0% 41.0% Higher Margin CRMD
Net Profit Margin Profitability 0.0% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -143.4% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 20% ($1โ€“$2) 3% ($5โ€“$13) Stronger Trend TLPH
Beta / 30D Volatility Risk Regime 1.11ฮฒ ยท 58% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk TLPH
Unified Institutional Score Composite Signal 37.1 / 100 (SELL) 53.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TLPH vs CRMD Buy Guide
TLPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TLPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TLPH nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.